To the Editor We read with interest the systematic review of the risk of intraocular bleeding with novel oral anticoagulants compared with warfarin. Sun and colleagues1 identified a modest relative risk reduction in intraocular bleeding with novel anticoagulants compared with warfarin in a meta-analysis of 12 randomized clinical trials with more than 100 000 patients.
Wormald R, Evans J. Risk of Intraocular Bleeding and the New Anticoagulants: Not Such a Big Effect. JAMA Ophthalmol. 2017;135(11):1281. doi:10.1001/jamaophthalmol.2017.4021
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: